220 related articles for article (PubMed ID: 18188859)
1. Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor.
Doyon J; Coesemans E; Boeckx S; Buntinx M; Hermans B; Van Wauwe JP; Gilissen RA; De Groot AH; Corens D; Van Lommen G
ChemMedChem; 2008 Apr; 3(4):660-9. PubMed ID: 18188859
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
3. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
[TBL] [Abstract][Full Text] [Related]
4. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
[TBL] [Abstract][Full Text] [Related]
5. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
[TBL] [Abstract][Full Text] [Related]
7. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
[TBL] [Abstract][Full Text] [Related]
8. Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.
Zhou C; Guo L; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Cascieri MA; Springer MS; Yang L
Bioorg Med Chem Lett; 2007 Jan; 17(2):309-14. PubMed ID: 17092717
[TBL] [Abstract][Full Text] [Related]
9. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
12. The discovery of novel cyclohexylamide CCR2 antagonists.
Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
[TBL] [Abstract][Full Text] [Related]
13. Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).
Paone DV; Shaw AW; Nguyen DN; Burgey CS; Deng JZ; Kane SA; Koblan KS; Salvatore CA; Mosser SD; Johnston VK; Wong BK; Miller-Stein CM; Hershey JC; Graham SL; Vacca JP; Williams TM
J Med Chem; 2007 Nov; 50(23):5564-7. PubMed ID: 17929795
[TBL] [Abstract][Full Text] [Related]
14. Novel small molecule bradykinin B2 receptor antagonists.
Gibson C; Schnatbaum K; Pfeifer JR; Locardi E; Paschke M; Reimer U; Richter U; Scharn D; Faussner A; Tradler T
J Med Chem; 2009 Jul; 52(14):4370-9. PubMed ID: 19552431
[TBL] [Abstract][Full Text] [Related]
15. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats.
Dansereau MA; Gosselin RD; Pohl M; Pommier B; Mechighel P; Mauborgne A; Rostene W; Kitabgi P; Beaudet N; Sarret P; Melik-Parsadaniantz S
J Neurochem; 2008 Jul; 106(2):757-69. PubMed ID: 18419759
[TBL] [Abstract][Full Text] [Related]
16. Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity.
Smith ND; Poon SF; Huang D; Green M; King C; Tehrani L; Roppe JR; Chung J; Chapman DP; Cramer M; Cosford ND
Bioorg Med Chem Lett; 2004 Nov; 14(22):5481-4. PubMed ID: 15482908
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.
Yang L; Zhou C; Guo L; Morriello G; Butora G; Pasternak A; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Ayala JM; Goyal S; Hanlon WA; Cascieri MA; Springer MS
Bioorg Med Chem Lett; 2006 Jul; 16(14):3735-9. PubMed ID: 16698264
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.
Terasaka T; Okumura H; Tsuji K; Kato T; Nakanishi I; Kinoshita T; Kato Y; Kuno M; Seki N; Naoe Y; Inoue T; Tanaka K; Nakamura K
J Med Chem; 2004 May; 47(11):2728-31. PubMed ID: 15139750
[TBL] [Abstract][Full Text] [Related]
20. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.
Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Tsutsumi T; Sudo M; Endo N; Muroga Y; Hada T; Fanning D; Saunders J; Kato Y; Myers PL; Tarby CM
Bioorg Med Chem Lett; 2008 Mar; 18(6):1869-73. PubMed ID: 18313297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
